BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1246 related articles for article (PubMed ID: 16428476)

  • 1. Epigenetic inactivation of Wnt inhibitory factor-1 plays an important role in bladder cancer through aberrant canonical Wnt/beta-catenin signaling pathway.
    Urakami S; Shiina H; Enokida H; Kawakami T; Tokizane T; Ogishima T; Tanaka Y; Li LC; Ribeiro-Filho LA; Terashima M; Kikuno N; Adachi H; Yoneda T; Kishi H; Shigeno K; Konety BR; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Jan; 12(2):383-91. PubMed ID: 16428476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.
    Taniguchi H; Yamamoto H; Hirata T; Miyamoto N; Oki M; Nosho K; Adachi Y; Endo T; Imai K; Shinomura Y
    Oncogene; 2005 Nov; 24(53):7946-52. PubMed ID: 16007117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
    Ramachandran I; Thavathiru E; Ramalingam S; Natarajan G; Mills WK; Benbrook DM; Zuna R; Lightfoot S; Reis A; Anant S; Queimado L
    Oncogene; 2012 May; 31(22):2725-37. PubMed ID: 22002305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection.
    Urakami S; Shiina H; Enokida H; Kawakami T; Kawamoto K; Hirata H; Tanaka Y; Kikuno N; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2109-16. PubMed ID: 16609023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt inhibitory factor-1 functions as a tumor suppressor through modulating Wnt/β-catenin signaling in neuroblastoma.
    Zhang J; Zhou B; Liu Y; Chen K; Bao P; Wang Y; Wang J; Zhou Z; Sun X; Li Y
    Cancer Lett; 2014 Jun; 348(1-2):12-9. PubMed ID: 24561119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer.
    Aguilera O; Fraga MF; Ballestar E; Paz MF; Herranz M; Espada J; García JM; Muñoz A; Esteller M; González-Sancho JM
    Oncogene; 2006 Jul; 25(29):4116-21. PubMed ID: 16491118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
    Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
    Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular activation of Wnt signaling through epigenetic dysregulation of Wnt inhibitory factor-1 (Wif-1) is associated with pathogenesis of adrenocortical tumor.
    Mitsui Y; Yasumoto H; Nagami T; Hiraki M; Arichi N; Ishikawa N; Araki A; Maruyama R; Tanaka Y; Dahiya R; Shiina H
    Oncotarget; 2014 Apr; 5(8):2198-207. PubMed ID: 24755523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
    Shin H; Kim JH; Lee YS; Lee YC
    Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines.
    Lin YC; You L; Xu Z; He B; Mikami I; Thung E; Chou J; Kuchenbecker K; Kim J; Raz D; Yang CT; Chen JK; Jablons DM
    Biochem Biophys Res Commun; 2006 Mar; 341(2):635-40. PubMed ID: 16427602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redundant expression of canonical Wnt ligands in human breast cancer cell lines.
    Benhaj K; Akcali KC; Ozturk M
    Oncol Rep; 2006 Mar; 15(3):701-7. PubMed ID: 16465433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
    Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
    Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
    Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
    Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetically regulated effects of Wnt antagonists on the expression of genes in the apoptosis pathway in human bladder cancer cell line (T24).
    Varol N; Konac E; Onen IH; Gurocak S; Alp E; Yilmaz A; Menevse S; Sozen S
    DNA Cell Biol; 2014 Jul; 33(7):408-17. PubMed ID: 24665856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines?
    Varol N; Konac E; Bilen CY
    Exp Biol Med (Maywood); 2015 May; 240(5):624-30. PubMed ID: 25349215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
    Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
    Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Wnt/beta-catenin/Tcf signaling pathway in human astrocytomas.
    Sareddy GR; Panigrahi M; Challa S; Mahadevan A; Babu PP
    Neurochem Int; 2009 Sep; 55(5):307-17. PubMed ID: 19576519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of WIF-1 by hypermethylation in astrocytomas.
    Yang Z; Wang Y; Fang J; Chen F; Liu J; Wu J; Wang Y; Song T; Zeng F; Rao Y
    Acta Biochim Biophys Sin (Shanghai); 2010 Jun; 42(6):418-25. PubMed ID: 20539942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 63.